Cargando…
Cost-effectiveness analysis of pre-ART HIV drug resistance testing in Kenyan women
BACKGROUND: The prevalence of pre-treatment drug resistance (PDR) to non-nucleoside reverse-transcriptase inhibitor (NNRTI) agents is increasing in sub-Saharan Africa, which may decrease the effectiveness of efavirenz-based antiretroviral therapy (ART) programs. However, due to recent safety concern...
Autores principales: | Duarte, Horacio A., Babigumira, Joseph B., Enns, Eva A., Stauffer, David C., Shafer, Robert W., Beck, Ingrid A., Garrison, Louis P., Chung, Michael H., Frenkel, Lisa M., Bendavid, Eran |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7256304/ https://www.ncbi.nlm.nih.gov/pubmed/32490370 http://dx.doi.org/10.1016/j.eclinm.2020.100355 |
Ejemplares similares
-
Projecting the potential impact of the Cap-Score™ on clinical pregnancy, live births, and medical costs in couples with unexplained infertility
por: Babigumira, Joseph B., et al.
Publicado: (2017) -
An in vitro evaluation of drugs used in the Kenyan ART program
por: Muriuki, Joseph, et al.
Publicado: (2016) -
Estimating the costs of HIV clinic integrated versus non-integrated treatment of pre-cancerous cervical lesions and costs of cervical cancer treatment in Kenya
por: Vodicka, Elisabeth L., et al.
Publicado: (2019) -
Addressing Pediatric HIV Pretreatment Drug Resistance and Virologic Failure in Sub-Saharan Africa: A Cost-Effectiveness Analysis of Diagnostic-Based Strategies in Children ≥3 Years Old
por: Siriruchatanon, Mutita, et al.
Publicado: (2021) -
Estimating the Cost of Illness of Giant Cell Arteritis in the United States
por: Babigumira, Joseph B., et al.
Publicado: (2017)